Related Articles
Evaluation of glypican‑3 in patients with hepatocellular carcinoma
Identification of a role for serum aldo‑keto reductase family 1 member B10 in early detection of hepatocellular carcinoma
Serum GP73 is complementary to AFP and GGT‑Ⅱ for the diagnosis of hepatocellular carcinoma
Blood MALT1 serves as a potential biomarker reflecting the response and survival of immune‑checkpoint‑inhibitor therapy in advanced hepatocellular carcinoma
Predictive effects of preoperative serum CA125 and AFP levels on post‑hepatectomy survival in patients with hepatitis B‑related hepatocellular carcinoma